MONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt ...
The choline chloride market is projected to grow from USD 617.60 million in 2025 to USD 671.75 million by 2026, and reach USD 1.05 billion by 2032, at a CAGR of 7.88%. This robust trajectory is driven ...
In reworking the connections within plastic materials, researchers are studying how plant-based compounds could eventually ...
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
The FDA has granted Fast Track designation to intravenous choline chloride (Protara Therapeutics), an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure ...
(RTTNews) - Protara Therapeutics, Inc. (TARA) announced Friday that it has reached alignment with the U.S. Food and Drug Administration (FDA) on a registrational path forward for intravenous (IV) ...
(MENAFN- GlobeNewsWire - Nasdaq) EU producers laud EU for addressing choline chloride dumping by China; measures will help preserve jobs and secure feed supply chain MONTVALE, N.J., Dec. 22, 2025 ...
18.20. NB Group Co., Ltd. 18.21. Nuproxa Switzerland Ltd. 18.22. PerkinElmer Inc. 18.23. Pestell Nutrition Inc. 18.24. PhytoTech Labs, Inc. 18.25. SDA Products 18.26 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results